Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Khorana AA - Despite the significant burden imposed by VTE and the availability of effective anticoagulant therapies, many oncology patients do not receive appropriate VTE prophylaxis as recommended by practice guidelines. Improved adherence to guidelines could substantially reduce morbidity, decrease resource use, enhance quality of life, and improve survival in these patients.

Related Articles

Anemia Drugs in Cancer Patients may Cause Thromboembolism
Internet Source, 11/13/09    Relevance Score: 68%

Drugs To Treat Anemia In Cancer Patients Linked To Thromboembolism
ScienceDaily, 11/11/09    Relevance Score: 68%

Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1
Thrombosis Research, 10/26/09    Relevance Score: 66%

Use of deep vein thrombosis prophylaxis in hospitalized cancer patients
Blood Coagulation & Fibrinolysis, 10/07/09    Relevance Score: 66%

Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study
Internal and Emergency Medicine, 10/01/09    Relevance Score: 66%

Today in Coagulation/Bleeding Dz...keeping you current

Intracranial Hemorrhage in Acute and Chronic Childhood Immune Thrombocytopenic Purpura over a Ten-Year Period: An Egyptian Multicenter Study
Acta Haematologica, 12/04/09

Hematological Issues in Critically Ill Patients with Cancer
Critical Care Clinics, 12/04/09

Pharmacokinetics and safety of fibrinogen concentrate
Journal of Thrombosis and Haemostasis, 12/03/09